Congratulations to resident Alex Gooding, MD, PhD, who is one of two winners of a 2024 Duke Cancer Institute Research Young Investigator Pilot Award. The award will support Dr. Gooding's research on genome-wide characterization of collateral sensitivities in osimertinib-resistant NSCLCs. Dr. Gooding is mentored by Kris Wood, PhD, associate professor of pharmacology and cancer biology and of cell biology.